THIRD STOCK OPTION AGREEMENTThird Stock Option Agreement • March 8th, 2016 • PharmaCyte Biotech, Inc. • Medicinal chemicals & botanical products • Nevada
This Third Stock Option Agreement (“Agreement”) is made as of the 30th day of December, 2015 by and between PharmaCyte Biotech, Inc. (“Company”) and Gerald W. Crabtree (“Participant”).
AMENDMENT NO. 1 TO EXECUTIVE COMPENSATION AGREEMENTExecutive Compensation Agreement • March 8th, 2016 • PharmaCyte Biotech, Inc. • Medicinal chemicals & botanical products
This Amendment No. 1 to Executive Compensation Agreement (“Amendment No. 1”), dated as of December 30, 2015, is made by and between PharmaCyte Biotech, Inc., a Nevada corporation (“Company”), and Kenneth L. Waggoner (“Executive”). The Company and the Executive are each referred to in this Amendment No. 1 as a “Party” and collectively as the “Parties.” Capitalized terms used but not defined in this Amendment No. 1 shall have the meanings given to them in the Executive Compensation Agreement (as defined below).
